Trial Profile
Efficacy and safety of tiotropium bromide and/or indacaterol in patients with chronic heart failure due to coronary artery disease combined with chronic obstructive pulmonary disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Oct 2015
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary) ; Indacaterol
- Indications Chronic heart failure; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 28 Oct 2015 New trial record
- 02 Sep 2015 Results presented at ESC Congress 2015: Annual Congress of the European Society of Cardiology.